ELENA
GALVE CALVO
Hospital Universitario de Basurto
Bilbao, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario de Basurto (14)
2024
-
Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients
Clinical and Translational Oncology
-
First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN
Breast Cancer Research and Treatment, Vol. 206, Núm. 2, pp. 317-328
-
Leveraging Large Language Models for Precision Monitoring of Chemotherapy-Induced Toxicities: A Pilot Study with Expert Comparisons and Future Directions
Cancers, Vol. 16, Núm. 16
2023
-
Narrative Review of Multidisciplinary Management of Central Nervous Involvement in Patients with HER2-Positive Metastatic Breast Cancer: Focus on Elderly Patients
Advances in Therapy, Vol. 40, Núm. 8, pp. 3304-3331
2022
2021
-
Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer
Clinical and Translational Oncology, Vol. 23, Núm. 7, pp. 1272-1280
2020
-
Probabilistic cost-utility analysis and expected value of perfect information for the Oncotype multigenic test: a discrete event simulation model
Gaceta Sanitaria, Vol. 34, Núm. 1, pp. 61-68
-
The economic burden of metastatic breast cancer in Spain
European Journal of Hospital Pharmacy , Vol. 27, Núm. 1, pp. 19-24
2018
-
Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: Pooled analysis in 4 basque country university hospitals
ClinicoEconomics and Outcomes Research, Vol. 10, pp. 189-199
-
Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/ HER2– advanced or metastatic breast cancer in Spain
ClinicoEconomics and Outcomes Research, Vol. 10, pp. 773-790
2017
-
Effectiveness and safety of Eribulin in metastatic breast cancer
European Journal of Clinical Pharmacy, Vol. 19, Núm. 1, pp. 55-59
2016
-
Albumin-Bound (NAB) Paclitaxel, Abraxane®
The Easy Book of Cancer Pharmacology (Nova Science Publishers, Inc.), pp. 7-17
-
Docetaxel.Taxotere®
The Easy Book of Cancer Pharmacology (Nova Science Publishers, Inc.), pp. 139-145
-
Gemcitabine. Gemzar®
The Easy Book of Cancer Pharmacology (Nova Science Publishers, Inc.), pp. 197-205